ClinicalTrials.gov
ClinicalTrials.gov Menu

Barriers to Adherence to Asthma Controller Meds in Low Income Urban Minority Adolescents (ADEPT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00967720
Recruitment Status : Completed
First Posted : August 28, 2009
Last Update Posted : November 21, 2017
Sponsor:
Information provided by:
Rush University Medical Center

Brief Summary:
Poor adherence to appropriate asthma medications is an important risk factor contributing to high asthma morbidity and mortality in urban African American adolescents. As part of the ADEPT (Adolescent Disease Empowerment and Persistency Technology) for Asthma Pilot 2 study, a focus group was developed specifically to explore existing barriers to adherence among inner city African American adolescent asthmatics.

Condition or disease
Asthma

Study Type : Observational
Actual Enrollment : 4 participants
Observational Model: Other
Time Perspective: Retrospective
Official Title: Qualitative Analysis of the Barriers to Adherence With Asthma Controller Medication Among Inner City African American Adolescents as Identified Through Focus Group Data
Study Start Date : March 2008
Actual Primary Completion Date : August 2009
Actual Study Completion Date : August 2009

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Group/Cohort
Barriers, Adherence, Asthma



Primary Outcome Measures :
  1. Focus groups explored whether a new communication medium improved adherence to asthma controller medications and to examine existing barriers to adherence among four urban African American adolescents with uncontrolled moderate persistent asthma


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   12 Years to 15 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
four low income urban adolescents with uncontrolled moderate persistent asthma
Criteria

Inclusion Criteria:

  • 12-18 years of age
  • self identify as African American
  • have persistent asthma
  • read at a minimum fourth grade reading level
  • be on a prescribed daily inhaled corticosteroid medication for asthma

Exclusion Criteria:

  • candidate refusal or presence of other co-morbidities

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00967720


Sponsors and Collaborators
Rush University Medical Center
Investigators
Principal Investigator: Giselle S Mosnaim, MD Rush University Medical Center

Responsible Party: Giselle Mosnaim, MD, Rush University Medical Center
ClinicalTrials.gov Identifier: NCT00967720     History of Changes
Other Study ID Numbers: 08021601
First Posted: August 28, 2009    Key Record Dates
Last Update Posted: November 21, 2017
Last Verified: November 2017

Additional relevant MeSH terms:
Asthma
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases